Cargando…
Clinico-pathological significance of exosome marker CD63 expression on cancer cells and stromal cells in gastric cancer
BACKGROUND: It has been reported that CD63, an exosome marker, is expressed in solid cancer tissues. However, its significance in patients with gastric cancer has not been clarified. Exosomes derived from cancer cells and stromal cells might play an important role in the intracellular communications...
Autores principales: | Miki, Yuichiro, Yashiro, Masakazu, Okuno, Tomohisa, Kuroda, Kenji, Togano, Shingo, Hirakawa, Kosei, Ohira, Masaichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141093/ https://www.ncbi.nlm.nih.gov/pubmed/30222750 http://dx.doi.org/10.1371/journal.pone.0202956 |
Ejemplares similares
-
CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells
por: Miki, Yuichiro, et al.
Publicado: (2018) -
Circulating CEA‐positive and EpCAM‐negative tumor cells might be a predictive biomarker for recurrence in patients with gastric cancer
por: Miki, Yuichiro, et al.
Publicado: (2020) -
Gastric cancer stem cells survive in stress environments via their autophagy system
por: Togano, Shingo, et al.
Publicado: (2021) -
Circulating tumor cells with FGFR2 expression might be useful to identify patients with existing FGFR2‐overexpressing tumor
por: Kuroda, Kenji, et al.
Publicado: (2020) -
Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer
por: Yashiro, Masakazu, et al.
Publicado: (2021)